Michael Gelfand, MD, PhD
Associate Professor of Clinical Neurology
Department: Neurology
Contact information
Department of Neurology
Hospital of the University of Pennsylvania
3400 Spruce Street
Philadelphia, PA 19104-4283
Hospital of the University of Pennsylvania
3400 Spruce Street
Philadelphia, PA 19104-4283
Office: 215-662-3606
Education:
BS & MS (Molecular Biophysics and Biochemistry )
Yale University, 2001.
PhD (Neuroscience)
Rockefeller University, 2009.
MD (Doctor of Medicine)
Weill Cornell Medical College, 2010.
BS & MS (Molecular Biophysics and Biochemistry )
Yale University, 2001.
PhD (Neuroscience)
Rockefeller University, 2009.
MD (Doctor of Medicine)
Weill Cornell Medical College, 2010.
Post-Graduate Training
Intern in Medicine, St. Luke`s-Roosevelt Hospital Center, New York, NY, 2010-2011.
Resident in Neurology, Hospital of the University of Pennsylvania, Philadelphia, PA, 2011-2014.
Fellow in Epilepsy/Neurophysiology, Hospital of the University of Pennsylvania, Philadelphia, PA, 2014-2015.
Intern in Medicine, St. Luke`s-Roosevelt Hospital Center, New York, NY, 2010-2011.
Resident in Neurology, Hospital of the University of Pennsylvania, Philadelphia, PA, 2011-2014.
Fellow in Epilepsy/Neurophysiology, Hospital of the University of Pennsylvania, Philadelphia, PA, 2014-2015.
Certifications
Neurology (American Board of Psychiatry and Neurology(ABPN)), 2014.
Epilepsy (American Board of Psychiatry and Neurology(ABPN)), 2016.
Permanent linkNeurology (American Board of Psychiatry and Neurology(ABPN)), 2014.
Epilepsy (American Board of Psychiatry and Neurology(ABPN)), 2016.
Description of Clinical Expertise
Epilepsy, EEG, Clinical Neurophysiology, Epilepsy Surgery, Antiepileptic Drugs, ElectrocorticographyDescription of Research Expertise
Clinical TrialsSelected Publications
Acton EK, Hennessy S, Gelfand MA, Leonard CE, Bilker WB, Shu D, Willis AW, Kasner SE.: Direct-Acting Oral Anticoagulants and Antiseizure Medications for Atrial Fibrillation and Epilepsy and Risk of Thromboembolic Events. JAMA Neurol 81: 835-844, Aug 2024.Emmert BE, Xie K, Conrad EC, Ghosn NJ, Bauman K, Korzun J, Kulick-Soper CV, Naveed O, Hartmann N, LaRocque JJ, Mindy Ganguly T, Gugger JJ, Raghupathi R, Gelfand MA, Davis KA, Sinha SR, Litt B, Shinohara RT, Ellis CA.: Alcohol for seizure induction in the epilepsy monitoring unit. Epilepsy Behav 2024.
Acton EK, Hennessy S, Gelfand MA, Leonard CE, Bilker WB, Shu D, Willis AW, Kasner SE.: Thinking Three-Dimensionally: A Self- and Externally-Controlled Approach to Screening for Drug-Drug-Drug Interactions Among High-Risk Populations. Clin Pharmacol Ther 2024.
Zhou DJ, Woodson-Smith S, Emmert BE, Kornspun A, Larocque J, Kulick-Soper CV, Qiu MK, Ellis CA, Gugger JJ, Conrad EC, Waldman G, Ganguly T, Sinha SR, Davis KA, Stein JM, Liu GT, Gelfand M, Raghupathi R.: Clinical characteristics and surgical outcomes of epilepsy associated with temporal encephalocele: A systematic review. Epilepsy Behav 2024.
French JA, Porter RJ, Perucca E, Brodie MJ, Rogawski MA, Pimstone S, Aycardi E, Harden C, Qian J, Rosenblut CL, Kenney C, Beatch GN; X-TOLE Study Group.: Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy: A Phase 2b Randomized Clinical Trial. JAMA Neurol 80: 1145-1154, Nov 2023.
Bases B, Barnard S, French JA, Pellinen J; Human Epilepsy Project.: Impact of Seizures While Driving Prior to Diagnosis in People With Focal Epilepsy: Motor Vehicle Accidents and Time to Diagnosis. Neurology 101: e1370-e1375, Sep 2023.
Kanner AM, Saporta AS, Kim DH, Barry JJ, Altalib H, Omotola H, Jette N, O'Brien TJ, Nadkarni S, Winawer MR, Sperling M, French JA, Abou-Khalil B, Alldredge B, Bebin M, Cascino GD, Cole AJ, Cook MJ, Detyniecki K, Devinsky O, Dlugos D, Faught E, Ficker D, Fields M, Gidal B, Gelfand M, Glynn S, Halford JJ, Haut S, Hegde M, Holmes MG, Kalviainen R, Kang J, Klein P, Knowlton RC, Krishnamurthy K, Kuzniecky R, Kwan P, Lowenstein DH, Marcuse L, Meador KJ, Mintzer S, Pardoe HR, Park K, Penovich P, Singh RK, Somerville E, Szabo CA, Szaflarski JP, Lin Thio KL, Trinka E, Burneo JG; Human Epilepsy Project.: Mood and Anxiety Disorders and Suicidality in Patients With Newly Diagnosed Focal Epilepsy: An Analysis of a Complex Comorbidity. Neurology 100: e1123-e1134, Mar 2023.
French J, Biton V, Dave H, Detyniecki K, Gelfand MA, Gong H, Liow K, O'Brien TJ, Sadek A, DiVentura B, Reich B, Isojarvi J.: A randomized phase 2b efficacy study in patients with seizure episodes with a predictable pattern using Staccato® alprazolam for rapid seizure termination. Epilepsia 2023.
Pellinen J, Pardoe H, Sillau S, Barnard S, French J, Knowlton R, Lowenstein D, Cascino GD, Glynn S, Jackson G, Szaflarski J, Morrison C, Meador KJ, Kuzniecky R; Human Epilepsy Project Investigators.: Later onset focal epilepsy with roots in childhood: Evidence from early learning difficulty and brain volumes in the Human Epilepsy Project. Epilepsia 2023.
Hina Dave, MD - UT Southwestern Medical Center; Jacqueline French, MD - NYU Comprehensive Epilepsy Center; Hamada Hamid Altalib, DO, MPH, FAES - Yale University; Heidi Henninger, MD - Maine Medical Center; Roger Porter, MD, ScD - Perelman School of Medicine, University of Pennsylvania; Michael Gelfand, MD, PhD - University of Pennsylvania; Melinda Martin, PhD - UCB Pharma, Smyrna; Prashant Dongre, MD - UCB Pharma, Smyrna; Sami Elmoufti, MS - UCB Pharma, Raleigh; Anne-Liv Schulz, MD - UCB Pharma, Monheim am Rhein; Michael Sperling, MD - Thomas Jefferson University: Real-World Study of Brivaracetam in the United States. American Epilepsy Society December 2021.